Pathway to Overcome Primary Packaging & Drug Product Manufacturing (F&F) Challenges. A Case Study on Ophthalmic Drugs

•   The global ophthalmic drug market is forecasted to reach $47.6 billion by 2030 with a growth driven by the rapidly ageing global population.     
• Silicon oil-free technology contributes to achieve low subvisible particles and enable consistent and predictable glide forces for a better drug product system.    
• The collaboration on fill & finish processes and primary containers contribute to improve filling accuracy, minimize headspace and maximize throughput while ensuring flexibility and time to market.     
• Established collaboration such as Terumo and Swissfillon offers a best-in-class solution for ophthalmic projects  

 If you have further questions or would like more information on this topic, meet us in person at Pharmapack in Paris! We'll be on stand E68.